Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Erratum to: Prognostic Markers in Peripheral T-Cell Lymphoma

Erratum to: Prognostic Markers in Peripheral T-Cell Lymphoma Curr Hematol Malig Rep (2010) 5:239 DOI 10.1007/s11899-010-0066-6 ERRATUM Erratum to: Prognostic Markers in Peripheral T-Cell Lymphoma Pier Paolo Piccaluga & Claudio Agostinelli & Anna Gazzola & Claudia Mannu & Francesco Bacci & Elena Sabattini & Stefano A. Pileri Published online: 28 September 2010 Springer Science+Business Media, LLC 2010 Erratum to: Curr Hematol Malig Rep DOI 10.1007/s11899-010-0062-x In the first paragraph in the “Gene Expression Profiling” section, the third sentence should say, “In particular, cases with higher levels of NFκB-related molecules or other evidence of NFκB activation showed better survival, with a median OS of 25 months (range 0–124 months) versus a median OS of 12 months (range 0–19 months) (P=0.032) [36, 38].” The online version of the original article can be found at doi:10.1007/ s11899-010-0062-x. : : : : P. P. Piccaluga (*) C. Agostinelli A. Gazzola C. Mannu : : F. Bacci E. Sabattini S. A. Pileri Department of Hematology and Oncological Sciences “L. and A. Seràgnoli”, Hematopathology Unit, S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti, 9, 40138 Bologna, Italy e-mail: pierpaolo.piccaluga@unibo.it http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Hematologic Malignancy Reports Springer Journals

Erratum to: Prognostic Markers in Peripheral T-Cell Lymphoma

Download PDF
1 page

Erratum to: Prognostic Markers in Peripheral T-Cell Lymphoma

Abstract

Curr Hematol Malig Rep (2010) 5:239 DOI 10.1007/s11899-010-0066-6 ERRATUM Erratum to: Prognostic Markers in Peripheral T-Cell Lymphoma Pier Paolo Piccaluga & Claudio Agostinelli & Anna Gazzola & Claudia Mannu & Francesco Bacci & Elena Sabattini & Stefano A. Pileri Published online: 28 September 2010 Springer Science+Business Media, LLC 2010 Erratum to: Curr Hematol Malig Rep DOI 10.1007/s11899-010-0062-x In the first paragraph in the “Gene Expression...
Loading next page...
 
/lp/springer-journals/erratum-to-prognostic-markers-in-peripheral-t-cell-lymphoma-tIqHctKwOR

References (2)

Publisher
Springer Journals
Copyright
Copyright © 2010 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Hematology
ISSN
1558-8211
eISSN
1558-822X
DOI
10.1007/s11899-010-0066-6
Publisher site
See Article on Publisher Site

Abstract

Curr Hematol Malig Rep (2010) 5:239 DOI 10.1007/s11899-010-0066-6 ERRATUM Erratum to: Prognostic Markers in Peripheral T-Cell Lymphoma Pier Paolo Piccaluga & Claudio Agostinelli & Anna Gazzola & Claudia Mannu & Francesco Bacci & Elena Sabattini & Stefano A. Pileri Published online: 28 September 2010 Springer Science+Business Media, LLC 2010 Erratum to: Curr Hematol Malig Rep DOI 10.1007/s11899-010-0062-x In the first paragraph in the “Gene Expression Profiling” section, the third sentence should say, “In particular, cases with higher levels of NFκB-related molecules or other evidence of NFκB activation showed better survival, with a median OS of 25 months (range 0–124 months) versus a median OS of 12 months (range 0–19 months) (P=0.032) [36, 38].” The online version of the original article can be found at doi:10.1007/ s11899-010-0062-x. : : : : P. P. Piccaluga (*) C. Agostinelli A. Gazzola C. Mannu : : F. Bacci E. Sabattini S. A. Pileri Department of Hematology and Oncological Sciences “L. and A. Seràgnoli”, Hematopathology Unit, S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti, 9, 40138 Bologna, Italy e-mail: pierpaolo.piccaluga@unibo.it

Journal

Current Hematologic Malignancy Reports – Springer Journals

Published: Sep 28, 2010

There are no references for this article.